Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding

Contributed by: ACCESS Newswire

Logo

ACCESSWIRE logo

Images

ACCESSWIRE associated3

Tags

Healthcare & Pharmaceutical
Spiden
Company Update

More Like This

PR Newswire associated0

SIBIONICS to Make Debut at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)

PR Newswire associated0

SIBIONICS Achieves Milestone: Receiving CE Mark for Its Groundbreaking GS1 Continuous Glucose Monitoring System

PR Newswire associated0

Zedsen partners with Imperial College Healthcare NHS Trust to clinically validate its novel non-invasive sensing technology

PR Newswire associated0

A. Menarini Diagnostics and Sinocare Announce Exclusive Distribution Agreement for New Continuous Glucose Monitoring System

PR Newswire associated0

/C O R R E C T I O N -- Menarini Silicon Biosystems/

PR Newswire associated0

Respiree teams up with Roche Diagnostics in APAC to introduce a new simplified way of hospital patient monitoring

PR Newswire associated0

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

PR Newswire associated0

MTD Group completes the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems and announces a significant investment plan for its European production sites